(Q44306490)

1 December 2017

Chemoradiation for adenocarcinoma of the anus (English)

1 reference

1 December 2017

0 references

1 reference

Michael Papagikos

1

1 reference

1 December 2017

Christopher H Crane

2

1 reference

1 December 2017

John Skibber

3

1 reference

1 December 2017

Nora A Janjan

4

1 reference

1 December 2017

Barry Feig

5

1 reference

1 December 2017

Miguel A Rodriguez-Bigas

6

1 reference

1 December 2017

Arthur Hung

7

1 reference

1 December 2017

Robert A Wolff

8

1 reference

1 December 2017

Marc Delclos

9

1 reference

1 December 2017

Edward Lin

10

1 reference

1 December 2017

Karen Cleary

11

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

International Journal of Radiation Oncology Biology Physics

1 December 2017

1 reference

1 December 2017

55

1 reference

1 December 2017

669-678

1 reference

1 December 2017

3

1 reference

Prognosis and recurrence patterns of anal adenocarcinoma

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Adenocarcinoma of the anal ducts. A series of 21 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Primary adenocarcinoma of the anus: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Adenocarcinoma of the anal glands

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

In regard to Joon et al. IJROBP 1999;45:1199-1205

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

The National Cancer Data Base report on carcinoma of the anus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Carcinoma of the anal canal, a clinical and pathologic study of 188 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Epidermoid cancer of the anus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Combined therapy for cancer of the anal canal: a preliminary report. 1974.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Combined radiotherapy and chemotherapy for anal cancer. EORTC Radiotherapy and Gastrointestinal Cooperative Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Adenocarcinomas of the anal canal and peri-anal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Malignant tumors of the anus. A study of 106 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Adenocarcinoma of the anal glands. Results of a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Anal adenocarcinoma: a comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Perianal mucinous adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Inguinal lymph node metastases from adenocarcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Management of inguinal lymph node metastases from adenocarcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904118-4

7 January 2021

10.1016/S0360-3016(02)04118-4

Identifiers

DOI

1 reference

1 December 2017

1 reference